Dr. Erika Hamilton discusses the most notable breast cancer treatments currently in development, and how might they change care for patients in the future.

A new study conducted by researchers from McGill University, the Lady Davis Institute for Medical Research (LDI) at the ...

Data from a research database link ctDNA positivity in early breast cancer with poorer survival and higher recurrence risk.

Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the issuance ...

“This dosing regimen patent reflects our commitment to enhancing our intellectual property portfolio,” said Brian Sullivan, CEO and Co-Founder of Celcuity. “With patent exclusivity for gedatolisib now ...

A new study has found that delaying surgery after a breast cancer diagnosis significantly increases the risk of breast cancer ...

Brunch presenter Morgan McGlynn Carr has shared a health update with fans after she revealed she was diagnosed with ...